Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer

ClinicalTrials.gov ID: NCT02705469

Public ClinicalTrials.gov record NCT02705469. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 2:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Safety and Tolerability Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open label, Phase 1, dose escalation and dose confirmation study of ZEN003694 in patients with mCRPC.

Study identification

NCT ID
NCT02705469
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Zenith Epigenetics
Industry
Enrollment
44 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2016 (Actual)
Primary completion
Oct 2017 (Actual)
Completion
Oct 2017 (Actual)
Last update posted
Nov 20, 2017

2016 – 2017

United States locations

U.S. sites
8
U.S. states
5
U.S. cities
8
Facility City State ZIP Site status
University of California Los Angeles Medical Center Los Angeles California — —
University of California San Francisco Medical Center San Francisco California — —
Karmanos Cancer Institute Detroit Michigan — —
Karmanos Cancer Institute Farmington Hills Michigan — —
Memorial Sloan Kettering Cancer Center New York New York — —
Oregon Health & Science University Portland Oregon — —
Virginia Oncology Associates Hampton Virginia — —
Virginia Oncology Associates Norfolk Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02705469, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 20, 2017 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02705469 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →